After Hours Summary: ATVI +9.7%, INFN +9.6%, SKX +8.9% higher following earnings... YELP -9%, MPWR -7.9%, CATM -7.6%, UBNT -7.2%, CERN -5.7% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: ATVI +9.7%, INFN +9.6%, SKX +8.9%, ASYS +8.1%, RPD +7.5%, SWIR +7%, CTRL +6.8%, ELLI +5.3%, ICHR +4.5%, COLM +4.4%, HDP +4.2%, NE +4.1%, TLND +3.9% (light volume), ATEN +2.6%, RGC +2.4%, ARCW +2.2%, LPLA +1.9%, CPST +1.6%, NWSA +1.6%
Companies trading higher in after hours in reaction to news: CBR +11.9% (Lone Star Value discloses 5.4% active stake, says has engaged, and may continue to engage, in general discussions with the Board and management team, including with respect to the composition of the Board), TRVG +8.6% (still checking), AVEO +6.1% (announces updates for its lead drug candidate, tivozanib; 'Pivotal TIVO-3 Trial Enrollment Proceeding Substantially Ahead of Schedule', not revising anticipated topline data time), HXL +3.4% (authorizes $300 million of additional share repurchases),
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: RSYS -15.3%, ONVO -14.1%, YELP -9%, MPWR -7.9%, CATM -7.6%, UBNT -7.2%, IPAS -6.3%, CERN -5.7%, MCFT -5%, ZNGA -4.8%, CYBR -4.7%, SGEN -4.5%, ZAYO -3.9%, APTI -3.8%, SANW -3.2%, MX -3%, WU -2.5%, EGAN -2.4%, P -2.1%, MHK -1.8%, TBBK -1.7%,
Companies trading lower in after hours in reaction to news: TCON -12.4% (reports top-line results from a randomized Phase 2 clinical trial of TRC105 in recurrent glioblastoma funded and conducted by the Clinical Therapy Evaluation Program (CTEP) of the National Cancer Institute), BTX -7% (commences common stock offering), CLF -4.8% (files mixed securities shelf offering; commences offering of 50 mln common shares or up to an aggregate of 57.5 mln Common Shares if the underwriter exercises its option), NBIX -0.8% (Neurocrine Biosci and BIAL enter into an exclusive licensing agreement for the development and commercialization of opicapone in North America)